{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T12:01:42Z","timestamp":1781265702955,"version":"3.54.1"},"reference-count":174,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jaip.2026.01.023","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T01:11:14Z","timestamp":1770253874000},"page":"560-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel Diagnostic Approaches for Eosinophilic Lung Diseases"],"prefix":"10.1016","volume":"14","author":[{"given":"Alexander","family":"Ruzic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merritt L.","family":"Fajt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.01.023_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/2040622315609251","article-title":"Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease","volume":"7","author":"George","year":"2016","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jaip.2026.01.023_bib2","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1111\/all.15884","article-title":"Eosinophils\u2014from cradle to grave","volume":"78","author":"Jesenak","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib3","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.mayocp.2021.04.025","article-title":"Eosinophils in health and disease: a state-of-the-art review","volume":"96","author":"Wechsler","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2026.01.023_bib4","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2214\/AJR.16.17315","article-title":"A review of clinical and imaging findings in eosinophilic lung diseases","volume":"208","author":"Bernheim","year":"2017","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jaip.2026.01.023_bib5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1164\/ajrccm.150.5.7952571","article-title":"Eosinophilic lung diseases","volume":"150","author":"Allen","year":"1994","journal-title":"Am J Respir Critical Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0720-048X(96)01029-7","article-title":"Pulmonary eosinophilia","volume":"23","author":"Bain","year":"1996","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jaip.2026.01.023_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.iac.2023.01.002","article-title":"Eosinophilic lung diseases","volume":"43","author":"Cottin","year":"2023","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2026.01.023_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jtho.2021.01.1616","article-title":"Biomarker discovery and validation: statistical considerations","volume":"16","author":"Ou","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jaip.2026.01.023_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chest.2017.03.001","article-title":"Acute eosinophilic pneumonia: correlation of clinical characteristics with underlying cause","volume":"152","author":"De Giacomi","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.023_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","article-title":"Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial","volume":"4","author":"Watz","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"389","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.01.023_bib12","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/rheumatology\/keu427","article-title":"al. Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis","volume":"54","author":"Grayson","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2026.01.023_bib13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1164\/rccm.201710-1967CI","article-title":"Acute eosinophilic pneumonia. Causes, diagnosis, and management","volume":"197","author":"De Giacomi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00005792-199809000-00001","article-title":"Idiopathic chronic eosinophilic pneumonia: a clinical and follow-up study of 62 cases","volume":"77","author":"Marchand","year":"1998","journal-title":"Medicine"},{"key":"10.1016\/j.jaip.2026.01.023_bib15","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1164\/ajrccm\/142.3.642","article-title":"Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils","volume":"142","author":"Allen","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2026.01.023_bib16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma","volume":"323","author":"Bousquet","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib17","series-title":"Global strategy for asthma management and prevention","year":"2024"},{"key":"10.1016\/j.jaip.2026.01.023_bib18","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1183\/09031936.96.09061174","article-title":"Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination","volume":"9","author":"Pizzichini","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib19","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.01.023_bib20","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.00146306","article-title":"Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial","volume":"29","author":"Siva","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1183\/09031936.06.00072105","article-title":"Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment","volume":"27","author":"Leigh","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","article-title":"Mepolizumab for prednisone-dependent asthma with sputum eosinophilia","volume":"360","author":"Nair","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib23","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01585-2021","article-title":"European Respiratory Society guidelines for the diagnosis of asthma in adults","volume":"60","author":"Louis","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib25","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.clinthera.2005.07.005","article-title":"Clinical applications of exhaled nitric oxide for the diagnosis and management of asthma: a consensus report","volume":"27","author":"Zitt","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaip.2026.01.023_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S2213-2600(25)00037-2","article-title":"Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials","volume":"13","author":"Meulmeester","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-2007-991527","article-title":"Bronchoalveolar lavage as a diagnostic tool","volume":"28","author":"Meyer","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1378\/chest.94.2.440","article-title":"Bronchoalveolar lavage-induced pneumothorax","volume":"94","author":"Krueger","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.023_bib29","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jacr.2022.04.010","article-title":"Complications after transthoracic needle biopsy of pulmonary nodules: a population-level retrospective cohort analysis","volume":"19","author":"Vachani","year":"2022","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.jaip.2026.01.023_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.resinv.2022.08.008","article-title":"Complications of a lung biopsy for severe respiratory failure: a systematic review and meta-analysis","volume":"61","author":"Sugimoto","year":"2023","journal-title":"Respir Investig"},{"key":"10.1016\/j.jaip.2026.01.023_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000537833","article-title":"Normal blood eosinophil counts in humans","volume":"103","author":"Lommatzsch","year":"2024","journal-title":"Respiration"},{"key":"10.1016\/j.jaip.2026.01.023_bib32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S2213-2600(19)30190-0","article-title":"Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial","volume":"7","author":"Pascoe","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib33","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.2174\/1389450119666180212120012","article-title":"Blood eosinophils as biomarkers to drive treatment choices in asthma and COPD","volume":"19","author":"Kostikas","year":"2018","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jaip.2026.01.023_bib34","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1164\/rccm.201807-1289LE","article-title":"Time of day affects eosinophil biomarkers in asthma: implications for diagnosis and treatment","volume":"198","author":"Durrington","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12931-019-1056-4","article-title":"Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis","volume":"20","author":"Prazma","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2026.01.023_bib36","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/all.14700","article-title":"Monitoring eosinophils to guide therapy with biologics in asthma: does the compartment matter?","volume":"76","author":"Koenderman","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib37","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S2213-2600(15)00419-1","article-title":"Blood or sputum eosinophils to guide asthma therapy?","volume":"3","author":"Mukherjee","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1183\/09031936.00201813","article-title":"Importance of concomitant local and systemic eosinophilia in uncontrolled asthma","volume":"44","author":"Schleich","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2013.03.044","article-title":"Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects","volume":"132","author":"Hastie","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib40","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(58)91385-0","article-title":"Treatment of chronic asthma with prednisolone significance of eosinophils in the sputum","volume":"272","author":"Morrow Brown","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.01.023_bib41","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1046\/j.1365-2222.2001.01133.x","article-title":"Repeatability and validity of cell and fluid-phase measurements in nasal fluid: a comparison of two methods of nasal lavage","volume":"31","author":"Belda","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib42","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/thx.51.10.1000","article-title":"Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD","volume":"51","author":"Ronchi","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2026.01.023_bib43","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1590\/S1806-37132008001100005","article-title":"Determination of the inflammatory component of airway diseases by induced sputum cell counts: use in clinical practice [article in English and Portuguese]","volume":"34","author":"Moritz","year":"2008","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.jaip.2026.01.023_bib44","doi-asserted-by":"crossref","first-page":"00871","DOI":"10.1183\/23120541.00871-2024","article-title":"The success rate and safety of induced sputum is better than you think: give it a try","volume":"11","author":"Moermans","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2026.01.023_bib45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1183\/09031936.06.00137704","article-title":"Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations","volume":"27","author":"Jayaram","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib46","doi-asserted-by":"crossref","first-page":"00914","DOI":"10.1183\/23120541.00914-2025","article-title":"Is it time for a simplified method to evaluate airway eosinophilia?","volume":"12","author":"Pignatti","year":"2026","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2026.01.023_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/20406223231190480","article-title":"Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases","volume":"14","author":"Ragnoli","year":"2023","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jaip.2026.01.023_bib48","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/all.14318","article-title":"Type 2 immunity in the skin and lungs","volume":"75","author":"Akdis","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib49","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1111\/all.16011","article-title":"Sputum cytokines associated with raised FeNO after anti-IL5 biologic therapy in severe asthma","volume":"79","author":"Hekking","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.rmed.2018.09.014","article-title":"Validation of ATS clinical practice guideline cut-points for FeNO in asthma","volume":"144","author":"Jeppegaard","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib51","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.chest.2021.04.013","article-title":"Eosinophilic and noneosinophilic asthma","volume":"160","author":"Heaney","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.023_bib52","series-title":"Focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group","year":"2020"},{"key":"10.1016\/j.jaip.2026.01.023_bib53","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0088-2024","article-title":"Biologics in severe asthma: a state-of-the-art review","volume":"34","author":"Gyawali","year":"2025","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2026.01.023_bib54","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","article-title":"Asthma","volume":"401","author":"Porsbjerg","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.01.023_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2026.01.023_bib56","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1183\/13993003.00097-2016","article-title":"Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"48","author":"Cottin","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib57","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1148\/radiol.10090105","article-title":"Imaging of pulmonary vasculitis","volume":"255","author":"Chung","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2026.01.023_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005792-198403000-00001","article-title":"Systemic vasculitis with asthma and eosinophilia","volume":"63","author":"Lanham","year":"1984","journal-title":"Medicine"},{"key":"10.1016\/j.jaip.2026.01.023_bib59","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis","volume":"390","author":"Wechsler","year":"2024","journal-title":"N Engl J Med"},{"issue":"suppl 68","key":"10.1016\/j.jaip.2026.01.023_bib60","article-title":"Late breaking abstract - benralizumab reduces eosinophils and ANCA in sputum in EGPA","volume":"64","author":"Mukherjee","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccm.2021.12.002","article-title":"Allergic bronchopulmonary aspergillosis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib62","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1378\/chest.116.3.639","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis","volume":"116","author":"Geller","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.023_bib63","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jaci.2018.06.023","article-title":"Allergic fungal rhinosinusitis","volume":"142","author":"Dykewicz","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib64","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jaip.2019.08.041","article-title":"Diagnostic cutoffs and clinical utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis","volume":"8","author":"Muthu","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.023_bib65","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaip.2020.08.043","article-title":"Which are the optimal criteria for the diagnosis of allergic bronchopulmonary aspergillosis? A latent class analysis","volume":"9","author":"Saxena","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.023_bib66","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.rmed.2004.07.002","article-title":"Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment","volume":"98","author":"Wark","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00408-024-00717-y","article-title":"Efficacy of biologics in patients with allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis","volume":"202","author":"Chen","year":"2024","journal-title":"Lung"},{"key":"10.1016\/j.jaip.2026.01.023_bib68","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1378\/chest.129.1_suppl.116S","article-title":"Chronic cough due to nonasthmatic eosinophilic bronchitis","volume":"129","author":"Brightling","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.023_bib69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1874306401711010017","article-title":"The emerging role of the eosinophil and its measurement in chronic cough","volume":"11","author":"Sadeghi","year":"2017","journal-title":"Open Respir Med J"},{"key":"10.1016\/j.jaip.2026.01.023_bib70","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/thorax.58.6.528","article-title":"Comparison of airway immunopathology of eosinophilic bronchitis and asthma","volume":"58","author":"Brightling","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2026.01.023_bib71","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1183\/09031936.00.16582400","article-title":"Airway inflammation in patients with symptoms suggesting asthma but with normal lung function","volume":"16","author":"Rytil\u00e4","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib72","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.chest.2016.10.003","article-title":"Eosinophils in COPD exacerbations are associated with increased readmissions","volume":"151","author":"Couillard","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.023_bib73","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.201502-0235LE","article-title":"Blood eosinophils: a biomarker of response to extrafine beclomethasone\/formoterol in chronic obstructive pulmonary disease","volume":"192","author":"Siddiqui","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib74","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","article-title":"Mepolizumab for eosinophilic chronic obstructive pulmonary disease","volume":"377","author":"Pavord","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib75","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1905248","article-title":"Benralizumab for the prevention of COPD exacerbations","volume":"381","author":"Criner","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib76","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1056\/NEJMoa2413181","article-title":"Mepolizumab to prevent exacerbations of COPD with an eosinophilic phenotype","volume":"392","author":"Sciurba","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib77","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2303951","article-title":"Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts","volume":"389","author":"Bhatt","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib78","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","article-title":"The idiopathic hypereosinophilic syndrome","volume":"83","author":"Weller","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.01.023_bib79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/all.15544","article-title":"Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes","volume":"78","author":"Valent","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib80","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2010.03.035","article-title":"Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence","volume":"126","author":"Crane","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib81","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1016\/j.jaip.2020.04.069","article-title":"Symptom assessment in hypereosinophilic syndrome: toward development of a patient-reported outcomes tool","volume":"8","author":"Kovacs","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.023_bib82","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.rmed.2010.09.011","article-title":"Lung involvement in hypereosinophilic syndromes","volume":"105","author":"Dulohery","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib83","doi-asserted-by":"crossref","unstructured":"Thomeer MJ, Costabe U, Rizzato G, Poletti V, M D. Comparison of registries of interstitial lung diseases in three European countries. Eur Respir J 32:114-8s.","DOI":"10.1183\/09031936.01.18s320114"},{"key":"10.1016\/j.jaip.2026.01.023_bib84","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00005792-198805000-00002","article-title":"Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature","volume":"67","author":"Jederlinic","year":"1988","journal-title":"Medicine"},{"key":"10.1016\/j.jaip.2026.01.023_bib85","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1183\/09031936.03.00085603","article-title":"Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?","volume":"22","author":"Marchand","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib86","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/030006059702500404","article-title":"Diagnostic problems in chronic eosinophilic pneumonia","volume":"25","author":"Matsuse","year":"1997","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jaip.2026.01.023_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.793409","article-title":"Biologics in asthma: a molecular perspective to precision medicine","volume":"12","author":"Salter","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2026.01.023_bib88","doi-asserted-by":"crossref","first-page":"307","DOI":"10.18176\/jiaci.0628","article-title":"Exacerbations of severe asthma while on anti\u2013IL-5 biologics","volume":"30","author":"Bhalla","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib89","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00117-2020","article-title":"Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena","volume":"56","author":"Mukherjee","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib90","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/cea.14220","article-title":"Airway autoimmunity, asthma exacerbations, and response to biologics","volume":"52","author":"Venegas Garrido","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib91","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2147\/COPD.S294333","article-title":"Mepolizumab for eosinophil-associated COPD: analysis of METREX and METREO","volume":"16","author":"Pavord","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2026.01.023_bib92","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/13993003.00779-2015","article-title":"Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort","volume":"46","author":"Shaw","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib93","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2025.05.031","article-title":"Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma","volume":"156","author":"McDowell","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib94","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.01.023_bib95","first-page":"00604","article-title":"A novel method to assess airway eosinophilia utilizing sputum plugs","volume":"12","author":"Patel","year":"2026","journal-title":"Eur Respir J Open Res"},{"key":"10.1016\/j.jaip.2026.01.023_bib97","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1164\/ajrccm.155.5.9154849","article-title":"Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment","volume":"155","author":"Pizzichini","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib98","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13223-021-00567-w","article-title":"Underestimation of airway luminal eosinophilia by quantitative sputum cytometry","volume":"17","author":"Kjarsgaard","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib99","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02446-2021","article-title":"Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma","volume":"60","author":"Klein","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib100","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaci.2013.12.1091","article-title":"Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes","volume":"133","author":"Baines","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib101","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaci.2018.12.1020","article-title":"A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma","volume":"144","author":"Fricker","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib102","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/thx.2010.156695","article-title":"Non-invasive phenotyping using exhaled volatile organic compounds in asthma","volume":"66","author":"Ibrahim","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2026.01.023_bib103","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1164\/rccm.202310-1759OC","article-title":"Discovery and validation of a volatile signature of eosinophilic airway inflammation in asthma","volume":"210","author":"Peltrini","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib104","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2007.05.043","article-title":"An electronic nose in the discrimination of patients with asthma and controls","volume":"120","author":"Dragonieri","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib105","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1164\/rccm.200906-0939OC","article-title":"Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma","volume":"180","author":"Fens","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib106","first-page":"24","article-title":"Analysis of fluid-phase mediators","volume":"37","author":"Kelly","year":"2002","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.jaip.2026.01.023_bib107","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jim.2017.11.005","article-title":"Endogenous peroxidases in sputum interfere with horse-radish peroxidase-based ELISAs","volume":"454","author":"Kim","year":"2018","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaip.2026.01.023_bib108","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1164\/rccm.202308-1413LE","article-title":"Benralizumab normalizes sputum eosinophilia in severe asthma uncontrolled by anti\u2013IL-5 antibodies: a single-blind, placebo-controlled clinical trial","volume":"208","author":"Mukherjee","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/all.15901","article-title":"Effect of dupilumab on sputum eosinophils in patients with moderate-to-severe asthma","volume":"79","author":"Svenningsen","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib111","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/all.12206","article-title":"Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia","volume":"68","author":"Nair","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib112","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/all.13711","article-title":"Rapid quantification of sputum eosinophil peroxidase on a lateral flow test strip","volume":"74","author":"Wolfe","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202307451","article-title":"A rapid sputum-based lateral flow assay for airway eosinophilia using an RNA-cleaving DNAzyme selected for eosinophil peroxidase","volume":"62","author":"Ali","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.jaip.2026.01.023_bib114","first-page":"1072","article-title":"Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory diseases","volume":"130","author":"Dor","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2026.01.023_bib115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1182\/blood.V72.1.150.150","article-title":"Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils","volume":"72","author":"Dvorak","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.01.023_bib116","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw4295","article-title":"Protein crystallization promotes type 2 immunity and is reversible by antibody treatment","volume":"364","author":"Persson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jaip.2026.01.023_bib117","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2217\/bmm-2018-0280","article-title":"Charcot-Leyden crystal protein\/galectin-10 is a surrogate biomarker of eosinophilic airway inflammation in asthma","volume":"13","author":"Nyenhuis","year":"2019","journal-title":"Biomark Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib118","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaci.2010.02.008","article-title":"Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes","volume":"125","author":"Hastie","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib119","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1021\/acs.jproteome.3c00389","article-title":"IL18R1-Related molecules as biomarkers for asthma severity and prognostic markers for idiopathic pulmonary fibrosis","volume":"22","author":"Lin","year":"2023","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jaip.2026.01.023_bib120","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chest.2016.11.024","article-title":"Quantitative CT measures of bronchiectasis in smokers","volume":"151","author":"Diaz","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.023_bib121","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.240717","article-title":"PiSlope: A new CT metric for quantifying airway remodeling in chronic obstructive pulmonary disease","volume":"313","author":"Bhatt","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2026.01.023_bib122","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaip.2026.01.023_bib123","series-title":"Mucus plug score predicts clinical and pulmonary function response to biologic therapy in patients with severe asthma","first-page":"1110","volume":"13","author":"G\u00f6tschke","year":"2025"},{"key":"10.1016\/j.jaip.2026.01.023_bib124","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.mric.2015.01.003","article-title":"Hyperpolarized gas MR imaging: techniques and applications","volume":"23","author":"Roos","year":"2015","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"10.1016\/j.jaip.2026.01.023_bib125","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1016\/j.acra.2023.03.010","article-title":"129Xe MRI ventilation defects in asthma: what is the upper limit of normal and minimal clinically important difference?","volume":"30","author":"McIntosh","year":"2023","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jaip.2026.01.023_bib126","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1148\/radiol.211433","article-title":"Hyperpolarized 129Xe MR spectroscopy in the lung shows 1-year reduced function in idiopathic pulmonary fibrosis","volume":"305","author":"Hahn","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2026.01.023_bib127","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.240949","article-title":"Assessing lung ventilation and bronchodilator response in asthma and chronic obstructive pulmonary disease with 19F MRI","volume":"313","author":"Pippard","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2026.01.023_bib129","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/mrm.26893","article-title":"Feasibility of quantitative regional ventilation and perfusion mapping with phase-resolved functional lung (PREFUL) MRI in healthy volunteers and COPD, CTEPH, and CF patients","volume":"79","author":"Voskrebenzev","year":"2018","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib130","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/jmri.27452","article-title":"Flow volume loop and regional ventilation assessment using phase-resolved functional lung (PREFUL) MRI: comparison with 129xenon ventilation MRI and lung function testing","volume":"53","author":"Kaireit","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jaip.2026.01.023_bib131","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1016\/j.acra.2024.01.039","article-title":"Phase-resolved functional lung (PREFUL) MRI to quantify ventilation: feasibility and physiological relevance in severe asthma","volume":"31","author":"Friedlander","year":"2024","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jaip.2026.01.023_bib132","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jmri.28844","article-title":"Non-contrast-enhanced functional lung MRI to evaluate treatment response of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a pilot study","volume":"59","author":"Benlala","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jaip.2026.01.023_bib133","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1164\/rccm.201310-1825OC","article-title":"Quantification of pulmonary inflammation after segmental allergen challenge using turbo-inversion recovery-magnitude magnetic resonance imaging","volume":"189","author":"Vogel-Claussen","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib134","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13244-025-01939-1","article-title":"Bronchial wall T2w MRI signal as a new imaging biomarker of severe asthma","volume":"16","author":"Benlala","year":"2025","journal-title":"Insights Imaging"},{"key":"10.1016\/j.jaip.2026.01.023_bib135","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/crj.13365","article-title":"Sputum processing by mechanical dissociation: a rapid alternative to traditional sputum assessment approaches","volume":"15","author":"Barber","year":"2021","journal-title":"Clin Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib136","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1378\/chest.119.5.1521","article-title":"Effect of physical and chemical methods of homogenization on inflammatory mediators in sputum of asthma patients","volume":"119","author":"Grebski","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.023_bib137","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1365-2222.2002.01409.x","article-title":"Optimizing sputum methodology","volume":"32","author":"Erin","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib138","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/thx.52.6.569","article-title":"\"Ultimate activation\" of eosinophils in vivo: lysis and release of clusters of free eosinophil granules (Cfegs)","volume":"52","author":"Persson","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2026.01.023_bib140","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jaci.2024.03.023","article-title":"Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma","volume":"154","author":"Tang","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib141","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1365-3156.2000.00649.x","article-title":"Eosinophil granule proteins in serum and urine of patients with helminth infections and atopic dermatitis","volume":"5","author":"Tischendorf","year":"2000","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jaip.2026.01.023_bib142","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/all.15481","article-title":"Urine eosinophil-derived neurotoxin: a potential marker of activity in select eosinophilic disorders","volume":"78","author":"Makiya","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib143","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cea.13302","article-title":"Fixed airflow obstruction relates to eosinophil activation in asthmatics","volume":"49","author":"Mogensen","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib144","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1164\/rccm.202310-1730OC","article-title":"Biomarker predictors of clinical efficacy of the anti-IgE biologic omalizumab in severe asthma in adults: results of the SoMOSA study","volume":"210","author":"Djukanovi\u0107","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib145","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1164\/rccm.201811-2210OC","article-title":"Exhaled volatile organic compounds are able to discriminate between neutrophilic and eosinophilic asthma","volume":"200","author":"Schleich","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib146","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2016.08.004","article-title":"Breathomics in the setting of asthma and chronic obstructive pulmonary disease","volume":"138","author":"Bos","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib147","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/10\/1\/016006","article-title":"Volatile organic compounds discriminate between eosinophilic and neutrophilic inflammation in vitro","volume":"10","author":"Schleich","year":"2016","journal-title":"J Breath Res"},{"key":"10.1016\/j.jaip.2026.01.023_bib148","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1378\/chest.09-1836","article-title":"Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma","volume":"137","author":"Montuschi","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.023_bib149","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jaci.2018.10.058","article-title":"Identification and prospective stability of electronic nose (eNose)\u2013derived inflammatory phenotypes in patients with severe asthma","volume":"143","author":"Brinkman","year":"2019","journal-title":"J Allergy Clinical Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib150","first-page":"431","article-title":"Inflammatory asthma phenotype discrimination using an electronic nose breath analyzer","volume":"25","author":"Plaza","year":"2015","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib151","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2024.07.012","article-title":"Multiomics analysis identified IL-4\u2013induced IL1RL1high eosinophils characterized by prominent cysteinyl leukotriene metabolism","volume":"154","author":"Sunata","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib152","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","article-title":"External validation of blood eosinophils, FENOand serum periostin as surrogates for sputum eosinophils in asthma","volume":"70","author":"Wagener","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2026.01.023_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205768","article-title":"Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis","volume":"13","author":"Rhee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2026.01.023_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40733-015-0019-x","article-title":"Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics","volume":"2","author":"Scichilone","year":"2016","journal-title":"Asthma Res Pract"},{"key":"10.1016\/j.jaip.2026.01.023_bib155","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/1750743X.2024.2439777","article-title":"Lebrikizumab decreases type 2 inflammatory biomarker levels in patients with asthma: data from randomized phase 3 trials (LAVOLTA I and II)","volume":"16","author":"Szefler","year":"2024","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaip.2026.01.023_bib156","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2017.06.033","article-title":"Sputum autoantibodies in patients with severe eosinophilic asthma","volume":"141","author":"Mukherjee","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib157","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13223-016-0174-5","article-title":"Airway autoimmune responses in severe eosinophilic asthma following low-dose mepolizumab therapy","volume":"13","author":"Mukherjee","year":"2017","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib158","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/rccm.201804-0809OC","article-title":"Sputum antineutrophil cytoplasmic antibodies in serum antineutrophil cytoplasmic antibody\u2013negative eosinophilic granulomatosis with polyangiitis","volume":"199","author":"Mukherjee","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib159","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1164\/rccm.202206-1183OC","article-title":"Autoantibody-mediated macrophage dysfunction in patients with severe asthma with airway infections","volume":"207","author":"Son","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib160","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00442-2022","article-title":"Airway autoantibodies are determinants of asthma severity","volume":"60","author":"Salter","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.023_bib161","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1164\/rccm.202412-2438OC","article-title":"Clinical remission by a comprehensive severe asthma management strategy guided by airway inflammometry and bioimaging","volume":"211","author":"Nolasco","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib162","doi-asserted-by":"crossref","first-page":"00097","DOI":"10.1183\/23120541.00097-2021","article-title":"The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils","volume":"7","author":"Ditz","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2026.01.023_bib163","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jaci.2016.08.048","article-title":"U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics","volume":"139","author":"Lefaudeux","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.023_bib164","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13325","article-title":"Proteomics in aging research: a roadmap to clinical, translational research","volume":"20","author":"Moaddel","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.jaip.2026.01.023_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2025.124867","article-title":"Development and validation of an LC-MS\/MS method for the simultaneous detection of urinary inflammatory biomarkers in a Flemish birth cohort","volume":"1269","author":"Den Ouden","year":"2026","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jaip.2026.01.023_bib166","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/all.12935","article-title":"Urinary metabolomic profiling of asthmatics can be related to clinical characteristics","volume":"71","author":"Loureiro","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.023_bib167","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20201133","article-title":"The emerging role of quantitative imaging in asthma","volume":"95","author":"Krings","year":"2022","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jaip.2026.01.023_bib168","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MCP.0b013e32834db255","article-title":"Computed tomography scans in severe asthma","volume":"18","author":"Walker","year":"2012","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib169","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.acra.2018.09.023","article-title":"The association between bronchial wall CT attenuation and spirometry in patients with bronchial asthma","volume":"26","author":"Matsushita","year":"2019","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jaip.2026.01.023_bib170","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1164\/rccm.202110-2265OC","article-title":"Mucus plugs persist in asthma, and changes in mucus plugs associate with changes in airflow over time","volume":"205","author":"Tang","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106982","article-title":"Luminal mucus plugs are spatially associated with airway wall thickening in severe COPD and asthma: a single-centered, retrospective, observational study","volume":"202","author":"Tran","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2026.01.023_bib172","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186889","article-title":"Cellular and molecular features of asthma mucus plugs provide clues about their formation and persistence","volume":"135","author":"Liegeois","year":"2025","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jaip.2026.01.023_bib173","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.alit.2024.03.001","article-title":"Eosinophil-mucus interplay in severe asthma: implications for treatment with biologicals","volume":"73","author":"Venegas Garrido","year":"2024","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2026.01.023_bib174","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170647","article-title":"Hyperpolarized gas MRI in pulmonology","volume":"91","author":"Kern","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jaip.2026.01.023_bib175","doi-asserted-by":"crossref","first-page":"00785","DOI":"10.1183\/23120541.00785-2020","article-title":"Xenon ventilation MRI in difficult asthma: initial experience in a clinical setting","volume":"7","author":"Mussell","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2026.01.023_bib176","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/mp.17009","article-title":"Pulmonary MRI with hyperpolarized xenon-129 demonstrates novel alterations in gas transfer across the air-blood barrier in asthma","volume":"51","author":"Qing","year":"2024","journal-title":"Med Phys"},{"key":"10.1016\/j.jaip.2026.01.023_bib177","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1378\/chest.12-2597","article-title":"Perfluoropropane gas as a magnetic resonance lung imaging contrast agent in humans","volume":"144","author":"Halaweish","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.023_bib178","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.70423","article-title":"Assessment of ventilation heterogeneity in severe asthma using phase-resolved functional lung magnetic resonance imaging","volume":"13","author":"Foo","year":"2025","journal-title":"Physiol Rep"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826000607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826000607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:49:56Z","timestamp":1781264996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826000607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":174,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2213219826000607"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.023","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Diagnostic Approaches for Eosinophilic Lung Diseases","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}